United States COVID-19 vaccine delivery to Mozambique

In an effective effort to make tremendous and recognizable contributions to help fight the spread of coronavirus, the United States Embassy in Mozambique has announced the arrival of more than two million doses of the Johnson & Johnson coordinated through COVAX in Maputo, Mozambique.

This is the United States’ fourth and largest bi-lateral COVID-19 vaccine delivery to Mozambique, bringing the total number of U.S.-donated vaccines to nearly 3.5 million, and maintaining the United States as Mozambique’s largest bi-lateral vaccine donor.

“The United States remains committed to sharing vaccines equitably, around the world,” U.S. Ambassador to Mozambique Dennis W. Hearne said. “No one is protected from COVID-19 until everyone is vaccinated. As more vaccines become available to all nations around the world, we have a shared interest in getting everyone who is eligible vaccinated.”

The U.S. Government has provided early and ongoing support for the response to the COVID-19 pandemic in Mozambique, including assistance valued at $62.5 million. This assistance includes the recent donation of 60 oxygen cylinders and a PSA oxygen plant, 50 ventilators, personal protective equipment for healthcare workers, laboratory and oxygen equipment, training, and funding for increased medical staff, among other initiatives.

In close collaboration with the Government of the Republic of Mozambique, the U.S. Government provides more than $500 million in annual assistance to improve the quality of education and healthcare, promote economic prosperity, and support the overall development of the nation.

The Mozambican government’s target is to vaccinate about 16.8 million people. Excluded from the vaccination are pregnant women and children under 15 years of age. According to the latest figures from the Health Ministry, the number of people fully vaccinated against the disease now stands at 3,324,849, and 6,158,360 have received at least one dose of the vaccine.

Mozambique shares borders with South Africa where a new COVID variant (B.1.1.529), renamed Omicron, is currently spreading. Travellers from the region are monitored. The United States, Europe and Asian States have restricted flights from southern African region, and that include Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique and Malawi.

Kester Kenn Klomegah
Kester Kenn Klomegah
MD Africa Editor Kester Kenn Klomegah is an independent researcher and writer on African affairs in the EurAsian region and former Soviet republics. He wrote previously for African Press Agency, African Executive and Inter Press Service. Earlier, he had worked for The Moscow Times, a reputable English newspaper. Klomegah taught part-time at the Moscow Institute of Modern Journalism. He studied international journalism and mass communication, and later spent a year at the Moscow State Institute of International Relations. He co-authored a book “AIDS/HIV and Men: Taking Risk or Taking Responsibility” published by the London-based Panos Institute. In 2004 and again in 2009, he won the Golden Word Prize for a series of analytical articles on Russia's economic cooperation with African countries.